1.76
Prelude Therapeutics Inc Aktie (PRLD) Neueste Nachrichten
Palantir, Shopify among market cap stock movers on Tuesday - Investing.com
Palantir, Uber among market cap stock movers on Tuesday By Investing.com - Investing.com UK
Incyte (INCY) Secures $935M Deal with Prelude Therapeutics for J - GuruFocus
Major Shift in PRLD Stock: What’s Behind the Surge? - StocksToTrade
Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next - ts2.tech
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga
Incyte inks option agreement with Prelude for JH2 inhibitor program - MSN
Prelude loses CMO, pauses SMARCA2 degraders and bags $60M from Incyte - Fierce Biotech
Prelude Therapeutics Signs Option Agreement with Incyte - TipRanks
Prelude Therapeutics’ Stock Performance: Rise or Risk? - timothysykes.com
Why Is Prelude Therapeutics Stock (PRLD) Down 45% Today? - TipRanks
Prelude Therapeutics pauses clinical development of SMARCA2 degrader program (PRLD:NASDAQ) - Seeking Alpha
Prelude Therapeutics Announces Management Changes - TradingView
Prelude to prioritize JAK2V617F JH2 inhibitor, KAT6A selective degrader programs - TipRanks
Prelude Therapeutics CMO Jane Huang departs - TipRanks
PRLD's Financial Outlook: Cash Runway Extended to 2027 - GuruFocus
Incyte (INCY) Secures Option for JAK2V617F Program in $910M Deal - GuruFocus
Incyte (INCY) Secures Exclusive Option on JAK2V617F Program - GuruFocus
Prelude Therapeutics sees cash runway into 2027 - TipRanks
Prelude Therapeutics pauses development of SMARCA2 degrader program - TipRanks
Prelude Therapeutics stock climbs after exclusive JAK2 option deal with Incyte - Investing.com Nigeria
Prelude Therapeutics shifts focus to JAK2 and KAT6A programs - Investing.com
A Look at Prelude Therapeutics Inc (PRLD) Shares in the Recent Past Indicates Growth - setenews.com
Incyte Enters Exclusive Option Agreement to Acquire Prelude Therapeutics' JAK2V617F Inhibitor Program for MPNs - Quiver Quantitative
Prelude Therapeutics Announces Strategic Business Update - Yahoo Finance
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors - Yahoo Finance
Is Prelude Therapeutics Incorporated stock supported by innovation pipelineJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Here's Why Prelude Therapeutics (NASDAQ:PRLD) Must Use Its Cash Wisely - 富途牛牛
Can Prelude Therapeutics Incorporated stock sustain free cash flow growth2025 Price Targets & AI Enhanced Trading Signals - newser.com
Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Can Prelude Therapeutics Incorporated stock hit analyst price targetsMarket Weekly Review & Safe Capital Growth Tips - newser.com
Will Prelude Therapeutics Incorporated stock deliver shareholder valueSwing Trade & Safe Investment Capital Preservation Plans - newser.com
What institutional flow reveals about Prelude Therapeutics IncorporatedMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Prelude Therapeutics (PRLD) Projected to Post Earnings on Wednesday - Defense World
Prelude Therapeutics Spikes: Can The Pipeline Keep Up? - RTTNews
Prelude Therapeutics (NASDAQ:PRLD) and CytoDyn (OTCMKTS:CYDY) Financial Analysis - Defense World
Prelude Therapeutics: A Subtle Shift In Pipeline Underscores Funding Challenges - Seeking Alpha
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com
Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus
Prelude Therapeutics announces publication of abstracts for ASH meeting - TipRanks
Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Yahoo Finance
Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Is Prelude Therapeutics Incorporated stock a defensive play in 2025Bond Market & Real-Time Market Sentiment Alerts - newser.com
How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com
Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS
Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK
What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com
Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):